Circulating tumour cells detected by a novel adenovirus-mediated system may be a potent therapeutic marker in gynaecological cancers

M. Takakura, S. Kyo, M. Nakamura, Y. Maida, Y. Mizumoto, Y. Bono, X. Zhang, Y. Hashimoto, Y. Urata, Toshiyoshi Fujiwara, M. Inoue

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: Recently developed detection system for circulating tumour cells (CTCs) using a telomerase-specific replicative adenovirus generated nonspecific green fluorescent protein (GFP) signals because of the co-presence of white blood cells (WBCs) nonspecifically infected by viruses. Here, we established a unique detection system for CTCs that completely excludes nonspecific signals.Methods:Blood obtained from the patients was subjected to haemolytic processes to eliminate red blood cells. The cell pellets were then infected with OBP-401, fixed, incubated with fluorescence-labelled anti-CD45 antibody to mark white blood WBCs, and examined on slides under a microscope.Results:Preparatory experiments with cancer cells artificially added to healthy donor samples confirmed that CD45 labelling could distinguish GFP-positive cancer cells from WBCs. In 53 patients with gynaecological cancers, CTCs were detected in 21 patients (39.6%) when CD45-positive cells were excluded as WBCs among GFP-positive cells. No CTCs were detected in samples from healthy volunteers. There was no significant correlation between CTC counts and known clinicopathological factors. The CTCs rapidly vanished after surgery or chemotherapy in most patients whose treatments were effective. In contrast, the persistence of CTCs even after treatments was tightly associated with poor response to the treatments (P

Original languageEnglish
Pages (from-to)448-454
Number of pages7
JournalBritish Journal of Cancer
Volume107
Issue number3
DOIs
Publication statusPublished - Jul 24 2012

    Fingerprint

Keywords

  • adenovirus
  • circulating tumour cells
  • GFP
  • gynaecological cancers
  • telomerase

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Takakura, M., Kyo, S., Nakamura, M., Maida, Y., Mizumoto, Y., Bono, Y., Zhang, X., Hashimoto, Y., Urata, Y., Fujiwara, T., & Inoue, M. (2012). Circulating tumour cells detected by a novel adenovirus-mediated system may be a potent therapeutic marker in gynaecological cancers. British Journal of Cancer, 107(3), 448-454. https://doi.org/10.1038/bjc.2012.276